2020
DOI: 10.1371/journal.pone.0226987
|View full text |Cite
|
Sign up to set email alerts
|

Proportions of CD4 test results indicating advanced HIV disease remain consistently high at primary health care facilities across four high HIV burden countries

Abstract: Background

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 14 publications
2
6
0
Order By: Relevance
“…One‐third of these HIV‐positive TB contacts had AHD (29%, 9/31), either immunologically defined (CD4 <200 cells/μL in 5/9) and/or clinically defined (WHO stage 3 or 4 found in 4/9). The overall proportion of AHD is in line with other AHD surveys from the region [ 1 , 2 , 3 ]. TB programme managers should factor in AHD screening and linkage to care of HIV‐positive TB contacts when discussing the efficiency of community TB contact‐tracing interventions, which have been often regarded as low efficient when the benefit is set only in their TB diagnosis yield [ 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ].…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…One‐third of these HIV‐positive TB contacts had AHD (29%, 9/31), either immunologically defined (CD4 <200 cells/μL in 5/9) and/or clinically defined (WHO stage 3 or 4 found in 4/9). The overall proportion of AHD is in line with other AHD surveys from the region [ 1 , 2 , 3 ]. TB programme managers should factor in AHD screening and linkage to care of HIV‐positive TB contacts when discussing the efficiency of community TB contact‐tracing interventions, which have been often regarded as low efficient when the benefit is set only in their TB diagnosis yield [ 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 ].…”
Section: Discussionsupporting
confidence: 87%
“…Despite the reduction in HIV incidence and AIDS‐mortality resulting from expanded access to antiretroviral treatment (ART) globally, more than one‐third of people living with HIV (PLHIV) continue to present to care with advanced HIV disease (AHD) in many low and middle income countries [ 1 , 2 , 3 ]. AHD is defined as having <200 CD4 cells/μL or World Health Organization (WHO) clinical stage 3 or 4 criteria [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Evidence suggests that even in access to treatment for all patients, a particular focus should be on AHD patients to reduce the high risk of HIV-related complications [ 12 ]. Prompt and early identification of patients with advanced HIV disease through CD4 testing is essential to reduce the burden of HIV in order to provide a specific treatment [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…HIV-infected patients in South Africa often present for treatment with advanced disease at lower CD4+ T cell counts and with higher viral loads [23,24]. This is associated both with an increased incidence of opportunistic and non-communicable complications of HIV infection and with longer and more severe chronic inflammation.…”
Section: Discussionmentioning
confidence: 99%